Abstract
The clerodane diterpenoid salvinorin A (1), the main active component of the psychotropic herb Salvia divinorum, has been reported to be a potent agonist at the κ‐opioid receptor. Computer modeling suggested that splendidin (2) from S. splendens, as well as related compounds, might possess similar activities. In the present study, this hypothesis was tested by determination of the binding properties of a series of structural congeners, compounds 2–8, at the μ‐, δ‐, and κ‐opioid receptors. However, none of these compounds showed significant binding to any of the opioid‐receptor subtypes, thus disproving the above hypothesis.
The novel compounds 7 and 8 were obtained semi‐synthetically by selective modification of salvifarin (5), isolated from Salvia farinacea, upon epoxide‐ring opening with AcOH in the presence of indium(III) triflate. Also, the X‐ray crystal structure of salvifaricin (6; Fig.), obtained from S. farinacea, was determined for the first time and used, in combination with in‐depth NMR experiments, to elucidate the absolute configurations of the new products. Our experiments demonstrate that the relatively well‐accessible diterpenoid 6 could be used as starting material for future studies into the structure–activity relationship at the κ‐opioid receptor.